-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Exelixis, Lowers Price Target to $57

Benzinga·11/13/2026 18:01:02
Diffusion vocale
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and lowers the price target from $60 to $57.